. TunkelAR, GlaserCA, BlochKC,; Infectious Diseases Society of America. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis2008; 47: 303–27.
. ChanPK, ChowPC, PeirisJS, MakAW, HuenKF. Use of oral valacyclovir in a 12-year-old boy with herpes simplex encephalitis. Hong Kong Med J2000; 6: 119–21.
5.
. SangdaraA, BhattarakosolP.Acyclovir susceptibility of herpes simplex virus isolates at King Chulalongkorn Memorial Hospital, Bangkok. J Med Assoc Thai2008; 9: 908–12.
. EdertDY, FinanceCM, Le FaouAE. Susceptibility of clinical strains of herpes simplex virus to three nucleoside analogues. Chemotherapy2000; 46: 195–7.
8.
. Package insert. Zovirax (oral acyclovir). Research Triangle Park, NC: GlaxoSmithKline, June 2005.
9.
. Package insert. Cytovene (ganciclovir). Nutley, NJ: Roche, August 1999.
10.
. BrasAP, SitarDS, AokiFY. Comparative bioavailability of acyclovir from oral valacyclovir and acyclovir in patients treated for recurrent genital herpes simplex virus infection. Can J Clin Pharmacol2001; 8: 207–11.
11.
. LykeJ, MalmeströmC, StåhleL.Acyclovir levels in serum and cerebrospinal fluid after oral administration of valacyclovir. Antimicrob Agents Chemother2003; 47: 2438–41.